Hoey Investments’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$803 Hold
134
﹤0.01% 365
2025
Q4
$961 Hold
134
﹤0.01% 366
2025
Q3
$1.43K Hold
134
﹤0.01% 350
2025
Q2
$1.3K Hold
134
﹤0.01% 352
2025
Q1
$2K Sell
134
-9
-6% -$138 ﹤0.01% 302
2024
Q4
$2.13K Sell
143
-48
-25% -$782 ﹤0.01% 292
2024
Q3
$3.95K Hold
191
﹤0.01% 267
2024
Q2
$3.95K Sell
191
-12
-6% -$238 ﹤0.01% 267
2024
Q1
$3.82K Sell
203
-9
-4% -$154 ﹤0.01% 263
2023
Q4
$3.06K Sell
212
-2
-0.9% -$27 ﹤0.01% 274
2023
Q3
$3.72K Sell
214
-7
-3% -$146 ﹤0.01% 268
2023
Q2
$4.6K Buy
221
+48
+28% +$1.04K ﹤0.01% 254
2023
Q1
$4.07K Sell
173
-2
-1% -$54 ﹤0.01% 265
2022
Q4
$4.89K Sell
175
-22
-11% -$563 ﹤0.01% 240
2022
Q3
$5K Sell
197
-207
-51% -$6.25K ﹤0.01% 262
2022
Q2
$14K Sell
404
-77
-16% -$2.7K 0.01% 174
2022
Q1
$17K Sell
481
-12
-2% -$410 ﹤0.01% 147
2021
Q4
$15K Sell
493
-2
-0.4% -$65 ﹤0.01% 160
2021
Q3
$16K Sell
495
-56
-10% -$1.79K ﹤0.01% 153
2021
Q2
$17K Buy
+551
New +$18.1K 0.01% 151

Other funds holding OGN

Hoey Investments's OGN Position: Q1 2026 in Review

Hoey Investments held its Organon & Co (OGN) position steady in Q1 2026 at 134 shares worth $803. The position accounts for ﹤0.01% of the portfolio, ranked #365.

Hoey Investments first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $17K in Q1 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Hoey Investments held 134 shares of Organon & Co worth $803 as of Q1 2026.
  • Hoey Investments left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of Hoey Investments's portfolio in Q1 2026, its #365 holding.
  • Hoey Investments first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • Hoey Investments's Organon & Co position peaked at $17K in Q1 2022.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Hoey Investments's 13F filing for Q1 2026, filed 29 Apr 2026.